Matthay, K K <br/><br/>
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.  [electronic resource] 

 -  The New England journal of medicine  Oct 1999 
 - 1165-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199910143411601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation--adverse effects<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Humans<br/>Infant<br/>Isotretinoin--adverse effects<br/>Life Tables<br/>Neuroblastoma--drug therapy<br/>Prospective Studies<br/>Risk<br/>Transplantation Conditioning<br/>Whole-Body Irradiation